GPT and hepatocellular carcinoma: A previous study has shown evidence that AST, ALT, and GGT were elevated in 90% of diagnosed patients with HCC, while half of the patients also exhibited an increase in bilirubin or liver-specific ALP concentrations [19], indicating that they can also be treated as additional but highly non-specific markers in HCCs.